Over 250 speakers are confirmed for the #WorldOrphanDrugCongress. EATRIS is a partner of the event dedicated to advancing the development and delivery of treatments for #RareDiseases.

Join us in Amsterdam on 28-29 Oct!

👉 Use the EATRIS 20% discount code here: https://loom.ly/GUPxOl8

We're excited to share that the Chairman of the BLACKSWAN Foundation, Dr. @oliviermenzel.bsky.social will be attending the World Orphan Drug Congress Europe from October 27 to 29, 2025!

#RAREvolution #WODC #WorldOrphanDrugCongress

#ICYMI we moderated a panel at the recent #WorldOrphanDrugCongress to discuss “The Future of #DrugDevelopment in #Rare and #OrphanDiseases: Navigating #Regulatory Challenges and #ClinicalInnovation." Catch the key takeaways at buff.ly/jXRnRn5

#RareDiseases #FDA

We out here repping @apstype1 and @rarediseasesinternational at the #worldorphandrugcongress

🚀 Exciting news: We are heading to the #WorldOrphanDrugCongress USA 2025!

We’re on a mission to accelerate research for #HSPB8 #myopathy, a rare and progressive disease with no treatment — yet.

📍 Stop by our poster & let’s connect to make breakthroughs happen!

#RareDisease #HSPB8Myopathy

Attending #WODC2025 next week? Stop by booth 614 and don't miss the panel, The Future of Drug Development in Rare and Orphan Diseases: Navigating Regulatory Challenges and Clinical Innovation

#WorldOrphanDrugCongress #RareDiseases #OrphanDrugs #ClinicalInnovation #RegulatoryAffairs #DrugDevelopment